The Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry (DISSRM)
Sponsor: Abramson Cancer Center at Penn Medicine
This observational or N/A phase trial investigates Kidney Neoplasm and is currently actively recruiting participants. Abramson Cancer Center at Penn Medicine leads this study, which shows 16 recorded versions since 2009 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
16 versions recorded-
Mar 2026 — Present [monthly]
Recruiting
-
Oct 2025 — Mar 2026 [monthly]
Recruiting
-
Sep 2024 — Oct 2025 [monthly]
Recruiting
-
Aug 2024 — Sep 2024 [monthly]
Recruiting
Status: Unknown → Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
▶ Show 11 earlier versions
-
Feb 2024 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Nov 2021 — Feb 2024 [monthly]
Recruiting
-
Jan 2021 — Nov 2021 [monthly]
Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Recruiting
-
Dec 2019 — Dec 2020 [monthly]
Recruiting
-
Mar 2019 — Dec 2019 [monthly]
Recruiting
-
Jan 2019 — Mar 2019 [monthly]
Recruiting
-
Jun 2018 — Jan 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2018 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jan 2018 [monthly]
Recruiting NA
First recorded
Jan 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abramson Cancer Center at Penn Medicine
- National Comprehensive Cancer Network
For direct contact, visit the study record on ClinicalTrials.gov .